30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

christer fåhraeus

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
christer fåhraeus's trades of EQL Pharma AB's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-18 2025-02-17
S Sale
29,294
340.93
SEK3,109,212 		29,294 340.93 SEK3,109,212
2024-03-15 2024-03-15
S Sale
79,435
290.51
SEK3,628,805 		79,435 290.51 SEK3,628,805
2023-12-12 2023-12-12
S Sale
34,563
240.79
SEK3,182,262 		34,563 240.79 SEK3,182,262
2023-11-24 2023-11-23
S Sale
90,000
30.22
SEK2,719,800 		90,000 30.22 SEK2,719,800
2019-11-27 2019-11-25
B Purchase
4,495
13.15
SEK59,109 		4,495 13.15 SEK59,109
2019-07-23 2019-07-19
B Purchase
230,000
12.00
SEK2,760,000 		230,000 12.00 SEK2,760,000
2018-11-21 2018-11-21
B Purchase
26,543
6.00
SEK159,258 		26,543 6.00 SEK159,258
2018-11-16 2018-11-13
B Purchase
1,698,922
6.00
SEK10,193,532 		1,698,922 6.00 SEK10,193,532
2017-09-15 2017-09-15
B Purchase
10,300
11.74
SEK120,922 		10,300 11.74 SEK120,922